Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pioneering Verification of the Use of the Immunomodulatory Effect of Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa With an Attempt to Optimize 577 nm and 810 nm Laser Protocols

NCT07088705 is registered in ClinicalTrials.gov with Marta P. Wiącek as lead sponsor.

NCT NCT07088705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07088705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pioneering Verification of the Use of the Immunomodulatory Effect of Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa With an Attempt to Optimize 577 nm and 810 nm Laser Protocols
Lead sponsor
Marta P. Wiącek
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 1, 2024
Completion date
February 28, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa (rp)